SCHEMBL12447641

SCHEMBL12447641

c1ccc2c(c1)c1ccccc1n2-c1cccc2c3ccccc3n(-c3ccc(-c4ccc(-n5c6ccccc6c6cccc(-n7c8ccccc8c8ccccc87)c65)cc4)cc3)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.48
KDM4E B2RXH2 2/20 0.48
ATM Q13315 1/20 0.48
ALDH1A1 P00352 3/20 0.42
HDAC4 P56524 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.37
FTO Q9C0B1 1/20 0.37
DUSP3 P51452 1/20 0.36
KMT2A Q03164 3/20 0.34
IL1R1 P14778 1/20 0.34
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
HTT P42858 2/20 0.33
PDE6D O43924 1/20 0.33
GPR3 P46089 1/20 0.33
POLB P06746 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26831036 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL26743786 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL22843267 0.94 KDM4E (0.54) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL21671477 0.93 KDM4E (0.57) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL24531653 0.90 L3MBTL1 (0.52) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL26743862 0.89 L3MBTL1 (0.43) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL21671297 0.89 L3MBTL1 (0.63) L3MBTL1KDM4EATMALDH1A1ALKBH5
SCHEMBL12447557 0.89 L3MBTL1 (0.63) L3MBTL1KDM4EATMALDH1A1ALKBH5
SCHEMBL12447547 0.89 L3MBTL1 (0.63) L3MBTL1KDM4EATMALDH1A1ALKBH5
SCHEMBL25009412 0.88 L3MBTL1 (0.46) L3MBTL1KDM4EATMALDH1A1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11818950-B2 Organic electroluminescence element NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-11-14 US disclosed
US-11818950-B2 Organic electroluminescence element NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-11-14 US disclosed
US-20200411770-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2020-12-31 US disclosed
EP-2521197-B1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL & SUMIKIN CHEM CO (JP) 2019-01-30 EP disclosed
US-9461250-B2 Organic electroluminescent device NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2016-10-04 US disclosed
US-9461250-B2 Organic electroluminescent device NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2016-10-04 US disclosed
EP-2521197-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Nippon Steel Chemical Co., Ltd. (JP) 2012-11-07 EP disclosed
US-20120235136-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2012-09-20 US disclosed
US-20120235136-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2012-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200411770-A1 ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, ILF2, TCF7L2 L3MBTL1 413/4885KDM4E 2679/4885ATM 2654/4885
US-11818950-B2 Organic electroluminescence element CCNE2, KCNN2, LEF1 L3MBTL1 437/4885KDM4E 2668/4885ATM 1956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.